Sengenics Video Library

Sengenics KREX technology for biomarker discovery, patient stratification and companion diagnostics

Other Videos

Sengenics Corporate Overview
KREX Protein Array Workflow
Sengenics p53 OncoREX Cancer Array launch seminar
SEROMAX Instruction Video
ImmuSAFE COVID+ Biochip Test
ImmuSAFE COVID+ Biochip Test for Vaccine Screening
ImmuSAFE COVID+ Biochip Test for Seroprevalence Studies

FEATURED PRODUCTS

High-throughput autoantibody profiling against 1600+ proteins

Quantification of autoantibodies to 200+ clinically relevant CT antigens

Simultaneous screening of 100+
wild-type and mutant p53

Multi-antigen, multi-domain
COVID-19 antibody test

Sengenics - Functional Proteomics | Krex Technology | Protein Microarray Supplier

Sengenics is a Functional Proteomics company that leverages its patented KREX technology to discover autoantibody biomarker signatures for prediction of drug response and severe immune-related adverse events (irAEs). KREX can also be used to identify autoantibody biomarkers to diagnose cancer, autoimmune, neurodegenerative or infectious diseases with higher sensitivity and specificity than conventional diagnostic tests. Some autoantibodies that are identified as diagnostic biomarkers may be protective and have potential in themselves as therapeutic biomolecules.

Copyright 2008 – 2021 Sengenics All rights reserved | Sengenics Corporation LLC. Registered in Delaware, USA no. 5739583 | Sengenics UK Registered in England and Wales no. 12889389

X